Post-Conference Perspectives: Recent Advances in the Management of Chronic GvHD - Episode 7

Real World Data on the Use of Ruxolitinib and Treatment Selection in chronic GvHD

,

Discussion centered around real-world data following the approval of ruxolitinib as a treatment option for patients with chronic GvHD as well as discussing treatment selection for patients with chronic GvHD, with special consideration for treatment sequencing.

EP. 1: The Chronic GvHD Landscape: Risk Factors and Diagnosis
EP. 2: First-line Treatment for Patients with Chronic GvHD
EP. 3: Defining and Managing Steroid Refractory Chronic GvHD
EP. 4: Role of Ruxolitinib in Steroid-Refractory Chronic GvHD
EP. 5: Understanding Mechanisms of Action: Ruxolitinib, Ibrutinib, and Belumosudil
EP. 6: Key Efficacy Data of Ibrutinib and Belumosudil in Steroid-Refractory Chronic GvHD Patients
Now Viewing
EP. 7: Real World Data on the Use of Ruxolitinib and Treatment Selection in chronic GvHD
EP. 8: Future Directions in Chronic GvHD